Yuyu Pharma, Inc. (KRX:000220)

Yuyu Pharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	73,065	72,903	85,445	102,750	130,082	108,199
Market Cap Growth	-14.68%	-14.68%	-16.84%	-21.01%	20.23%	62.16%
Enterprise Value	76,483	76,861	119,950	114,352	120,293	117,748
Last Close Price	4515.00	4505.00	5162.01	6081.01	7509.62	6924.50
PE Ratio	9.75	9.62	-	-	-	108.35
PS Ratio	0.55	0.55	0.62	0.74	1.13	1.10
PB Ratio	0.54	0.54	0.71	0.83	1.01	0.92
P/TBV Ratio	0.61	0.61	0.81	0.93	1.11	0.99
P/FCF Ratio	4.10	4.09	-	-	-	-
P/OCF Ratio	2.93	2.92	203.03	-	28.85	-
EV/Sales Ratio	0.57	0.58	0.87	0.82	1.04	1.20
EV/EBITDA Ratio	4.18	4.21	24.69	25.78	21.09	11.58
EV/EBIT Ratio	6.05	6.11	-	-	100.23	18.78
EV/FCF Ratio	4.29	4.31	-	-	-	-
Debt / Equity Ratio	0.25	0.25	0.33	0.32	0.30	0.17
Debt / EBITDA Ratio	1.84	1.84	8.11	8.86	6.87	1.96
Debt / FCF Ratio	1.89	1.89	-	-	-	-
Asset Turnover	0.66	0.66	0.70	0.72	0.67	0.67
Inventory Turnover	1.98	1.98	2.11	2.64	2.89	2.60
Quick Ratio	0.97	0.97	1.14	0.86	2.43	2.20
Current Ratio	1.58	1.58	2.03	1.50	3.30	3.50
Return on Equity (ROE)	8.06%	8.06%	-4.55%	-3.51%	-0.75%	2.32%
Return on Assets (ROA)	3.88%	3.88%	-0.24%	-0.19%	0.43%	2.68%
Return on Capital (ROIC)	4.79%	4.79%	-0.29%	-0.22%	0.49%	3.08%
Return on Capital Employed (ROCE)	8.80%	8.80%	-	-	0.70%	4.60%
Earnings Yield	10.37%	11.96%	-8.40%	-5.83%	-1.70%	1.19%
FCF Yield	24.41%	24.47%	-4.79%	-11.20%	-1.20%	-13.60%
Dividend Yield	2.21%	-	-	-	-	-
Payout Ratio	-	-	-	-	-	118.38%
Buyback Yield / Dilution	-3.29%	-3.29%	1.89%	-3.90%	-32.81%	19.87%
Total Shareholder Return	-1.10%	-3.29%	1.89%	-3.90%	-32.81%	19.87%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.